ArticleScience advances2025
Thiol-polarity dual cascade-triggered two-photon imaging of protein unfolding for early atherosclerosis diagnosis.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Renal Clearable Luminogenic Reporter for Ultrasensitive Influenza Virus Imaging and Efficient Antiviral Therapies Monitoring in Living Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein unfolding has emerged as a critical factor in the initiation and progression of atherosclerosis. Direct visualization of unfolded proteins remains technically challenging yet critical for elucidating atherosclerosis pathogenesis and developing early diagnostic tools. Here, we report a dual-reporter unlocking two-photon fluorescence probe for dynamic tracking of unfolded proteins in early atherosclerotic plaques. The probe achieves synergistic fluorescence activation through covalent binding with exposed thiols and subsequent stabilization within the local hydrophobic microenvironment of unfolded proteins. This dual-activation property allows for precise differentiation between folded and unfolded proteins in foam cells, facilitating spatiotemporal mapping of protein disorder at various stages of atherosclerosis. Notably, the probe detects early-stage unknown or tiny plaques within 4 to 8 weeks by identifying protein unfolding events before conventional Oil Red O staining and clinical ultrasonography, demonstrating unprecedented sensitivity for subclinical plaque prediction. Our findings establish a paradigm for investigating proteostasis disorder in atherogenesis and introduce a powerful molecular tool for early atherosclerosis diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.